Commercial biotechnology: an international analysis
This report assesses the competitive position of the United States with respect to Japan and four European countries - the Federal Republic of Germany, the United Kingdom, Switzerland, and France - believed to be the major competitors in the commercial development of new biotechnology. Although the United States is currently the world leader in both basic science and commercial development of new biotechnology, continuation of the initial preeminence of American companies in the commercialization of new biotechnology is not assured. Japan and other countries have identified new biotechnology as a promising area for economic growth and have therefore invested quite heavily in R and D in this field. Congressional policy options for improving US competitveness in new biotechnology are identified in this report.
- Research Organization:
- Office of Technology Assessment (U.S. Congress), Washington, DC
- OSTI ID:
- 6482352
- Report Number(s):
- OTA-BA-218; ON: TI85902089
- Country of Publication:
- United States
- Language:
- English
Similar Records
Eighth international NEA/Seabed Working Group meeting Varese, Italy, May 30-June 3, 1983
Summary of principal new (1/1/82 - 4/1/83) developments relating to the siting of waste management facilities. 1983 supplement to IEAL-232
Related Subjects
140504* -- Solar Energy Conversion-- Biomass Production & Conversion-- (-1989)
29 ENERGY PLANNING, POLICY, AND ECONOMY
290500 -- Energy Planning & Policy-- Research
Development
Demonstration
& Commercialization
292000 -- Energy Planning & Policy-- Supply
Demand & Forecasting
293000 -- Energy Planning & Policy-- Policy
Legislation
& Regulation
299003 -- Energy Planning & Policy-- Unconventional Sources & Power Generation-- Other-- (-1989)
550200 -- Biochemistry
550700 -- Microbiology
59 BASIC BIOLOGICAL SCIENCES
ABSTRACTS
ANIMAL CELLS
COMMERCIAL SECTOR
COMMERCIALIZATION
COMPETITION
COOPERATION
DNA
DOCUMENT TYPES
ECONOMIC ANALYSIS
ECONOMIC DEVELOPMENT
ECONOMICS
EDUCATION
ENERGY POLICY
ENVIRONMENTAL IMPACTS
GENETIC ENGINEERING
GOVERNMENT POLICIES
HYBRIDOMAS
INSTITUTIONAL FACTORS
INTERNATIONAL COOPERATION
LEADING ABSTRACT
MANPOWER
NATIONAL ORGANIZATIONS
NORTH AMERICA
NUCLEIC ACIDS
ORGANIC COMPOUNDS
POLITICAL ASPECTS
PROPERTY RIGHTS
PUBLIC OPINION
RECOMBINANT DNA
TECHNOLOGY TRANSFER
TECHNOLOGY UTILIZATION
TRAINING
US ORGANIZATIONS
US OTA
USA